BriaCell Therapeutics (TSE:BCT) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
BriaCell Therapeutics has announced its plans to sell common shares and warrants in an underwritten public offering. The company aims to use the proceeds for working capital, corporate purposes, and advancing its business goals. The offering’s completion depends on market conditions and there is no guarantee it will be finalized.
For further insights into TSE:BCT stock, check out TipRanks’ Stock Analysis page.